CN103037894A - 创伤治疗的乳铁蛋白序列、组合物及方法 - Google Patents

创伤治疗的乳铁蛋白序列、组合物及方法 Download PDF

Info

Publication number
CN103037894A
CN103037894A CN201180037142XA CN201180037142A CN103037894A CN 103037894 A CN103037894 A CN 103037894A CN 201180037142X A CN201180037142X A CN 201180037142XA CN 201180037142 A CN201180037142 A CN 201180037142A CN 103037894 A CN103037894 A CN 103037894A
Authority
CN
China
Prior art keywords
lobe
blf
lactoferrin
pharmaceutical composition
corneal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201180037142XA
Other languages
English (en)
Chinese (zh)
Inventor
本杰明·大卫·阿什比
齐安·加勒特
马克·威尔科克斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brien Holden Vision Institute Ltd
Original Assignee
Brien Holden Vision Institute Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010902932A external-priority patent/AU2010902932A0/en
Application filed by Brien Holden Vision Institute Ltd filed Critical Brien Holden Vision Institute Ltd
Publication of CN103037894A publication Critical patent/CN103037894A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN201180037142XA 2010-07-01 2011-07-01 创伤治疗的乳铁蛋白序列、组合物及方法 Pending CN103037894A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2010902932A AU2010902932A0 (en) 2010-07-01 Lactoferrin sequences, compositions and methods of wound treatment
AU2010902932 2010-07-01
PCT/AU2011/000826 WO2012000054A1 (en) 2010-07-01 2011-07-01 Lactoferrin sequences, compositions and methods of corneal wound treatment

Publications (1)

Publication Number Publication Date
CN103037894A true CN103037894A (zh) 2013-04-10

Family

ID=45401232

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201180037142XA Pending CN103037894A (zh) 2010-07-01 2011-07-01 创伤治疗的乳铁蛋白序列、组合物及方法

Country Status (10)

Country Link
US (1) US20130101575A1 (https=)
EP (1) EP2588128A4 (https=)
JP (1) JP2013530990A (https=)
CN (1) CN103037894A (https=)
AU (1) AU2011274244A1 (https=)
CA (1) CA2803932A1 (https=)
IN (1) IN2013CN00089A (https=)
SG (1) SG186841A1 (https=)
TW (1) TW201204384A (https=)
WO (1) WO2012000054A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117024518A (zh) * 2023-08-29 2023-11-10 百葵锐(深圳)生物科技有限公司 一种生物活性肽及其应用
CN118146346A (zh) * 2024-05-09 2024-06-07 杭州岛屿星晴生物技术有限公司 一种仿生胎脂蛋白肽的制备方法及其产品和应用

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20110606A1 (it) * 2011-11-16 2013-05-17 Ist Superiore Sanita Peptidi della lattoferrina per lo uso come inibitori ad ampio spettro dellainfezione da virus della influenza.
US11376311B2 (en) 2017-11-02 2022-07-05 Colorado Seminary, Owner and Operator of University of Denver Methods of treating microbial infection and inflammation

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004024180A1 (en) * 2002-09-16 2004-03-25 Agennix Incorporated Lactoferrin compositions and methods of wound treatment
WO2007043900A1 (en) * 2005-10-14 2007-04-19 Auckland Uniservices Limited Use of lactoferrin fragments and hydrolysates
US20090202574A1 (en) * 2004-11-19 2009-08-13 Jagat Rakesh Kanwar Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer
US20100092497A1 (en) * 2006-12-22 2010-04-15 Jagat Rakesh Kanwar Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2840795B2 (ja) * 1990-11-13 1998-12-24 参天製薬株式会社 角膜障害治療剤

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004024180A1 (en) * 2002-09-16 2004-03-25 Agennix Incorporated Lactoferrin compositions and methods of wound treatment
US20090202574A1 (en) * 2004-11-19 2009-08-13 Jagat Rakesh Kanwar Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer
WO2007043900A1 (en) * 2005-10-14 2007-04-19 Auckland Uniservices Limited Use of lactoferrin fragments and hydrolysates
US20100092497A1 (en) * 2006-12-22 2010-04-15 Jagat Rakesh Kanwar Methods of immune or haematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117024518A (zh) * 2023-08-29 2023-11-10 百葵锐(深圳)生物科技有限公司 一种生物活性肽及其应用
CN118146346A (zh) * 2024-05-09 2024-06-07 杭州岛屿星晴生物技术有限公司 一种仿生胎脂蛋白肽的制备方法及其产品和应用

Also Published As

Publication number Publication date
SG186841A1 (en) 2013-02-28
IN2013CN00089A (https=) 2015-07-03
JP2013530990A (ja) 2013-08-01
AU2011274244A1 (en) 2013-01-10
EP2588128A1 (en) 2013-05-08
TW201204384A (en) 2012-02-01
WO2012000054A1 (en) 2012-01-05
US20130101575A1 (en) 2013-04-25
CA2803932A1 (en) 2012-01-05
EP2588128A4 (en) 2014-03-19

Similar Documents

Publication Publication Date Title
JP5438968B2 (ja) 両親媒性ポリマー−ｐｄｇｆ複合体
TW201709916A (zh) 用於防止上皮細胞增生及上皮－間質轉移之組合物及方法
US11723954B2 (en) Therapeutic and cosmetic uses and applications of calreticulin
US5155038A (en) Use of thrombospondin to promote wound healing
JP2023179739A (ja) 角膜の混濁および瘢痕化の予防および治療のための組成物および方法
CN103037894A (zh) 创伤治疗的乳铁蛋白序列、组合物及方法
HK1182337A (en) Lactoferrin sequences, compositions and methods of corneal wound treatment
AU2015384099B2 (en) Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease
US20230391831A1 (en) Formulation for wound healing
US20210260167A1 (en) Lubricin for use in wound healing
US20260034223A1 (en) Biomimetic extracellular matrix nanofibers electrospun with calreticulin
WO2022204331A1 (en) Compositions comprising branched kgf-2 derived peptides and methods for use in ocular treatment
HK1241379B (zh) 短合成肽及其治疗和/或预防乾眼症的用途
HK1213499B (zh) 羊膜製品和純化的組合物及其使用方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1182337

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130410

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1182337

Country of ref document: HK